AntimalarialsArtemisininsChloroquinePlasmodium falciparumParasitic Sensitivity TestsMefloquineMalariaQuinineProgram EvaluationMalaria, FalciparumSesquiterpenesDrug ResistanceFluorenesSulfadoxinePyrimethaminePlasmodium cynomolgiPhenanthrenesPlasmodiumTetraoxanesDrug CombinationsProguanilTanzaniaAmodiaquineParasitemiaSelf MedicationProgram DevelopmentPlasmodium bergheiQuinolinesEthanolaminesTrophozoitesSpiro CompoundsBlackwater FeverDosage FormsPeroxidesInhibitory Concentration 50PrimaquineProtozoan ProteinsHydroxychloroquineAtovaquoneDapsoneErythrocytesCase ManagementDrug DiscoveryAsia, SoutheasternCambodiaHemeproteinsGovernment ProgramsDrug Evaluation, PreclinicalFeverFolic Acid AntagonistsNigeriaKenyaParasitesDrug Therapy, CombinationSudanUgandaPregnancy Complications, ParasiticMalaria, VivaxAminoquinolinesHealth PolicyThailandPlasmodium vivaxNaphthyridinesUnited StatesNational Health ProgramsLife Cycle StagesTabletsDrug Resistance, MultipleTreatment OutcomeTetrahydrofolate DehydrogenaseAfricaHealth PromotionCross-Sectional StudiesLupus Erythematosus, SystemicMolecular StructureHemeMembrane Transport ProteinsManaged Care ProgramsHealth EducationStructure-Activity RelationshipImmunization ProgramsSoftwareDrug DesignHemoglobinsDNA, ProtozoanCurriculumAnti-Bacterial AgentsDrug InteractionsInternship and ResidencyCommunity Health ServicesQuestionnairesMass ScreeningExercise TherapyPilot ProjectsSchool Health ServicesPatient Education as TopicHealth Knowledge, Attitudes, PracticeFellowships and ScholarshipsCost-Benefit Analysis